Treatment of urinary tract infections in condition of growing antibiotic resistance: Antimicrobial Stewardship program
Journal Title: УКРАЇНСЬКИЙ ЖУРНАЛ НЕФРОЛОГІЇ ТА ДІАЛІЗУ - Year 2019, Vol 3, Issue 63
Abstract
Resistance to common groups of antibiotics has been increasing in the treatment of urinary tract infections worldwide. In the United States, CDC has estimated that more thаn 2 million infections and 23,000 deaths are due to antibiotic resistance each year. In Europe, an еstimated 25,000 deaths are attributable to antibiotic-rеsistant infections. By 2050, it is estimated that antibiotic resistance will cause 10 million deaths every year.At the EU/EEA level, more than half (58.2%) of the E. coli isolates reported to EARS-Net for 2017 were resistant to at least one of the antimicrobial groups under regular surveillance, i.e. aminopenicillins, fluoroquinolones, third-generation cephalosporins, aminoglycosides and carbapenems. A majority (87.4%) of the third-generation cephalosporin-resistant E. coli isolates from 2017 were extended-spectrum beta-lactamase (ESBL)-positive. Use of broad-spectrum antimicrobials is a known risk factor for colonization and spread of resistant Enterobacteriaceae, including E. coli. The high levels of ESBLs and increasing resistance to key antimicrobial groups might also lead to an increased consumption of carbapenems, which in turn can increase the selection pressure and facilitated the spread of carbapenem-resistant Enterobacteriaceae. According to annual reports of CDC, WHO, EARS-Net and others,estimate that 30 percent of all antibiotics prescribed in outpatient clinics and 40 percent of all antibiotics prescribed in inpatient clinics were unnecessary. Improving the way we use antibiotics, often referred to as «antibiotic stewardship», is part of the National Action Plan. Appropriate antibiotic use means using the right antibiotic, at theright dose, for the right duration, and at the right time. The article reflects the recommendations of the European Association of Urology 2019 on the management and treatment of urinary tract infections in accordance with the principles of Antimicrobial Stewardship Program.
Authors and Affiliations
O. I. Chub, O. V. Bilchenko, O. M. Godlevska
СИСТЕМНІ ЕФЕКТИ ЛОКАЛЬНОЇ ПРОДУКЦІЇ ПРО- ТА ПРОТИФІБРОГЕННИХ МЕДІАТОРІВ У ХВОРИХ НА ХХН V ПД
Результати досліджень останніх років демонструють вирішальну роль медіаторів фіброгенезу у розвитку перитонеального фіброзу у ПД-пацієнтів. Метою роботи було визначити інтраперитонеальну продукцію моноцитарного хемотакс...
TREATMENTOFRENAL ALLOGRAFTCHRONIC REJECTION
The work is a literature review, which demonstrates the current strategies of the treatment of chronic renal allograft rejection
INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL ON INDICATORS OF TUBULO- INTERSTITIAL RENAL DAMAGE IN PATIENTS WITH CKDI-II: GLOMERULONEPHRITIS
The aim: to examine the relations between morphological tubulointerstitial (TIT) parameters of kidney damage and neutrophil gelatinase-associated lipocalin (NGAL) and interleukin-18 (IL-18) of blood serum in patients wit...
Функціональний стан нирок у дітей, що перенесли гостре пошкодження нирок, в катамнезі спостереження.
Гостре пошкодження нирок (ГПН) у дітей має поліетіологічну структуру, особливості перебігу залежні від віку захворювання і високий ризик розвитку хронічної хвороби нирок (ХХН) в катамнезі. Метою дослідження стало вивчен...
The possibility of using citrulline as a new biochemical marker to evaluate the state of kidney under cardiovascular pathologies
The aim of our work was to study the level of citrulline in serum as a biochemical marker of the functional state of the kidneys in patients with cardiovascular pathologies. Methods. The study included 134 patients aged...